The global Venous Leg Ulcer (VLU) Treatment Market will register a 16.71% cagr in terms of revenue, the global market size will reach us$ 169.50 million by 2027.
A venous leg ulcer is a long-term chronic sore on the inside of the leg, directly above the ankle. It can develop as a result of a small injury in which the skin has been injured by chronically high pressure in the veins. According to the NHS, the most frequent type of leg ulcer is a venous leg ulcer, which accounts for over 90% of all occurrences and affects almost 1 in 500 persons in the UK. The rise in the prevalence of venous leg ulcers and the use of compression therapy for the treatment of venous leg ulcers are the primary drivers of market expansion throughout the forecast period.
Rising knowledge regarding the availability of treatment options for venous leg ulcers, as well as innovations in treatment processes, are expected to drive the VLU treatment market growth during the forecast period.
This report contains data on sales and revenue for the past and predicted periods of time (2022 to 2027). Understanding the segments aids in determining the importance of various market growth variables. This Venous Leg Ulcer Treatment Market study assesses estimates of the CAGR value for a certain forecast period, market drivers, market restraints, and competitive strategies.
Top key players in the Venous Leg Ulcer (VLU) Treatment market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Venous Leg Ulcer (VLU) Treatment market is fragmented with a large number of small players operating worldwide. The companies referred to in the market research report include Alliancebernstein Holding LP (NYSE: AB), Integra Lifesciences Holdings Corp(NASDAQ: IART), Cardinal Health Inc (NYSE: CAH), 3M co (NYSE: MMM), Mölnlycke Health Care, Smith & Nephew plc., URGO Medical, Bauerfeind, PAUL HARTMANN AG, SIGVARIS and other.
Integra LifeSciences Announces Launch of Integra(R) Flowable Wound Matrix in Europe for Diabetic Foot and Leg Ulcers
Jan. 18, 2013-- announced that it has received European CE Mark Certification for its Integra Flowable Wound Matrix, an advanced device approved in the European Union for filling deep soft tissue or tunnelling wounds, including diabetic foot and leg ulcers.Integra LifeSciences Announces Launch Of Integra(R) Flowable Wound Matrix In Europe For Diabetic Foot And Leg Ulcers Integra LifeSciences Announces Launch Of Integra(R) Flowable Wound Matrix In Europe For Diabetic Foot And Leg Ulcers
Market is segmented based on the type, applications, companies and regions.
By type, Venous Leg Ulcer (VLU) Treatment Market has been segmented into
The end user’s industry application on Venous Leg Ulcer (VLU) Treatment Market is,
Because of public initiatives connected to diabetes, North America is likely to have a dominating position in the worldwide vascular ulcers treatment market over the forecast period. The Centers for Disease Control and Prevention (CDC) added a new Social Determinants of Health (SDOH) module to the U.S. Diabetes Surveillance System on November 17, 2020, to aid in identifying underserved areas of the country and assessing the potential impact of health disparities on diabetes burden and risk factors. The SDOH module gives public health professionals and researchers a more in-depth look at the factors that may influence people's capacity to successfully manage and prevent type 2 diabetes across the United States.
North america
The Venous Leg Ulcer (VLU) Treatment market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The global Venous Leg Ulcer (VLU) Treatment market report also conducted a pestel analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report attributes | Report details |
Report title | Venous Leg Ulcer (VLU) Treatment Market - global growth, trends and forecast (2022 - 2027) by types, by application, by regions and by key players: Alliancebernstein Holding LP (NYSE: AB), Integra Lifesciences Holdings Corp(NASDAQ: IART), Cardinal Health Inc (NYSE: CAH), 3M co (NYSE: MMM) |
Forecast period 2022 to 2028 cagr | Cagr of 16.71% over the forecast period (2022-2027) |
By type |
|
By application |
|
By companies | Alliancebernstein Holding LP (NYSE: AB), Integra Lifesciences Holdings Corp(NASDAQ: IART), Cardinal Health Inc (NYSE: CAH), 3M co (NYSE: MMM), Mölnlycke Health Care, Smith & Nephew plc., URGO Medical, Bauerfeind, PAUL HARTMANN AG, SIGVARIS |
Regions covered |
|
Countries covered |
|
Base year | 2022 |
Historical year | 2017 to 2021 |
Forecast year | 2022 to 2027 |
Number of pages | 108 |
Customization available | Yes, the report can be customized as per your needs |
Frequently asked questions
What is the study period of this Market?
The Venous Leg Ulcer (VLU) Treatment market is studied from 2017 - 2027.
What is the growth rate of the Venous Leg Ulcer (VLU) Treatment Market?
The Venous Leg Ulcer (VLU) Treatment market is growing at a cagr of 16.71% over the next 5 years.
Who are the key players in the Venous Leg Ulcer (VLU) Treatment Market?
Alliance Bernstein Holding LP (NYSE: AB), Integra Lifesciences Holdings Corp (NASDAQ: IART), Cardinal Health Inc (NYSE: CAH), 3M co (NYSE: MMM), Mölnlycke Health Care, Smith & Nephew plc., URGO Medical, Bauerfeind, PAUL HARTMANN AG, SIGVARIS
What regions does this Venous Leg Ulcer (VLU) Treatment Market report covers?
North america (the united states, canada, and mexico)
europe (germany, france, uk, russia, and italy)
asia-pacific (china, japan, korea, india, and southeast asia)
south america (brazil, argentina, colombia, etc.)
The middle east and africa (saudi arabia, uae, egypt, nigeria, and south africa)
What are the significant types of Venous Leg Ulcer (VLU) Treatment Market?
Compression Therapy, Advanced Wound Dressings, Others
What are the major end-use applications of the Venous Leg Ulcer (VLU) Treatment Market?
Hospitals, Specialty Clinics, Homecare Settings, Others
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.